Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SINUS-52: Dupilumab in Severe Chronic Rhinosinusitis with Nasal Polyps
NCT02898454Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2016
- Primary completion
- Aug 2018
- Modality
- Monoclonal Antibodies
- Countries
- 14
01
Overview
A Phase 3 trial of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Sanofi. Started Nov 2016; status: completed.
02
Drugs
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT02898454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02898454.